A closer look at the chemistry, containment, purification, peptide manufacturing, and sustainability challenges shaping modern API development. Play Now >>
From personalized dosing to on-demand production, explore how digital tablets are transforming pharma. Join us for a webinar on July 22 to see what's next.
Nwachuku will be responsible for managing the strategy, operations & commercial maximization of xPloration, OmniAb’s proprietary high-throughput single B-cell screening platform.
EMA and FDA are looking beyond efficacy to real-world usability. Discover why 3D printing is entering the therapeutic conversation. Read the full story in the "Manufacturing as Strategy" eBook from Contract Pharma.
Thermo Fisher Scientific provides sterile fill-finish development and manufacturing for biologics, small molecules and mRNA therapeutics, supporting programs from preclinical and first-in-human stages through commercial supply. Capabilities span liquid and lyophilized vials, prefilled syringes, cartridges, and small- and large-volume parenterals.
As a premier, independently owned CDMO with over 65+ years of sterile injectable manufacturing experience, Simtra BioPharma Solutions (Simtra) offers world-class cGMP sterile fill/finish, technical expertise, quality service, and a uniquely collaborative approach. Pharmaceutical and biotech companies partner with Simtra when they face formulation challenges, clinical supply hurdles, surges in demand due to market fluctuations, or risk mitigation concerns. Our teams are driven to offer clients tailored and versatile solutions to help them bring their products to market.
